🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The goal of this clinical research study is to find the highest tolerable d...
Status
Withdrawn
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01189513
Treatments Being Tested
Head and neck squamous cell carcinoma (HNSCC) is the most common cancer ari...
Status
Terminated
Location
UPMC Presbyterian
Start Date
2015-09
Trial ID
NCT02277184
Treatments Being Tested
Phase 2 multicenter, controlled, randomized, double-blind study to evaluate...
Status
Terminated
Location
UCSF Fresno
Start Date
2014-11
Trial ID
NCT02318368
Treatments Being Tested
Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient...
Status
No Longer Available
Location
START
Start Date
TBD
Trial ID
NCT02090127
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of ficlatuz...
Status
Recruiting
Location
Banner MD Anderson Cancer Center
Start Date
2024-01-11
Trial ID
NCT06064877
Treatments Being Tested
The purpose of this study is to see if ficlatuzumab when combined with cyta...
Status
Terminated
Location
University of California, San Francisco
Start Date
2015-05-01
Trial ID
NCT02109627
Treatments Being Tested
This screening and multi-sub-study Phase 1b/2 trial will establish a method...
Status
Recruiting
Location
Mayo Clinic Arizona
Start Date
2016-11
Trial ID
NCT03013998
Treatments Being Tested
During Phase 1b portion, there will be a dose-escalation of AV-299 (formerl...
Status
Completed
Location
Investigational Site 1
Start Date
2009-12
Trial ID
NCT01039948
Treatments Being Tested
This randomized phase II trial studies how well ficlatuzumab with or withou...
Status
Completed
Location
The University of Arizona Cancer Center
Start Date
2017-12-05
Trial ID
NCT03422536
Treatments Being Tested
This is a Phase 2, randomized, open-label, multicenter study to evaluate th...
Status
Withdrawn
Location
Multiple Locations
Start Date
2020-01-31
Trial ID
NCT04100330
Treatments Being Tested